Robert a. Eisenberg

Robert a. Eisenberg's AcademicInfluence.com Rankings

Robert a. Eisenberg

Philosophy

#8871

World Rank

#12332

Historical Rank

Logic

#5882

World Rank

#7329

Historical Rank

philosophy Degrees

Robert a. Eisenberg

Biology

#12077

World Rank

#15527

Historical Rank

Immunology

#802

World Rank

#825

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Robert a. Eisenberg's Degrees

PhD Immunology University of Pennsylvania
Doctorate Medicine University of Pennsylvania

Why Is Robert a. Eisenberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert a. Eisenberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains (1978) (1588)
Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. (1991) (1290)
"Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. (1995) (351)
An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity (1991) (213)
The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. (1992) (211)
A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis (2011) (199)
Systemic immunological effects of cytokine genes injected into skeletal muscle. (1993) (190)
Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice (2011) (170)
Selection of the T cell receptor repertoire in Lpr mice. (1993) (164)
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes (1979) (154)
Autoantibodies in chronic graft versus host result from cognate T-B interactions (1990) (152)
Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. (1983) (152)
Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice (1980) (150)
TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus1 (2007) (147)
IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. (1979) (145)
The therapeutic potential of anti-CD20 "what do B-cells do?". (2005) (131)
The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. (1999) (126)
Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery (1995) (117)
Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. (2002) (108)
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination (2013) (106)
Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. (1987) (104)
B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus (2006) (104)
Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I (1995) (102)
Use of bovine conglutinin for the assay of immune complexes. (1977) (101)
Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. (1980) (100)
V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. (1993) (89)
T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. (1994) (88)
A comparative immunologic analysis of several murine strains with autoimmune manifestations. (1980) (87)
The role of toll-like receptors in systemic lupus erythematosus (2006) (82)
Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: correlation of distribution and persistence with experimental arthritis in rats (1982) (81)
Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice (1993) (80)
Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. (1978) (78)
Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. (1985) (76)
Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides (1981) (75)
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes (2008) (74)
Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. (1989) (70)
lpr T cells are necessary for autoantibody production in lpr mice. (1993) (69)
Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. (1990) (69)
Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. (1980) (68)
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery. (2008) (67)
Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. (1995) (66)
The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. (2009) (64)
Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. (1990) (63)
The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation (1988) (63)
The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. (1998) (60)
Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. (1993) (60)
Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum. (1978) (59)
bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. (1995) (59)
The Yaa gene‐mediated acceleration of murine lupus: Yaa− T cells from non‐autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo (1995) (59)
The subclass distribution of human IgG rheumatoid factor. (1987) (58)
Chronic Graft-Versus-Host in Ig Knockin Transgenic Mice Abrogates B Cell Tolerance in Anti-Double-Stranded DNA B Cells1 (2002) (56)
Why can't we find a new treatment for SLE? (2009) (55)
Accelerated atherosclerosis in ApoE deficient lupus mouse models. (2008) (55)
Effect of castration on male-determined acceleration of autoimmune disease in BXSB mice. (1980) (54)
Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. (1990) (54)
Update on rituximab (2005) (53)
Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. (1993) (53)
Subclass restriction of anti-Sm antibodies in MRL mice. (1982) (50)
Natural thymocytotoxic autoantibodies in autoimmune and normal mice. (1979) (49)
SLE - Rituximab in lupus (2003) (48)
Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. (1996) (47)
Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls. (1982) (45)
Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice. (1988) (45)
Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. (1999) (45)
Intradural herniated cervical disk: a case report and review of the literature. (1986) (44)
Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases. (1994) (44)
Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice. (1988) (43)
Serum-serum interactions in autoimmune mice. (1979) (41)
B cell receptor editing in tolerance and autoimmunity (2011) (40)
Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. (1987) (40)
Anti-idiotypic antibodies to the Coombs antibody in NZB F1 mice (1982) (40)
Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. (1986) (39)
Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin (1984) (39)
B Cell Depletion with Anti-CD79 mAbs Ameliorates Autoimmune Disease in MRL/lpr Mice1 (2008) (39)
Interleukin 2 responses of lpr and normal L3T4-/Lyt-2- T cells induced by TPA plus A23187. (1987) (39)
Antigen nonspecific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus-prone lpr mice. (1993) (38)
The Mer Receptor Tyrosine Kinase Is Required for the Loss of B Cell Tolerance in the Chronic Graft-versus-Host Disease Model of Systemic Lupus Erythematosus1 (2008) (37)
Anti-Sm autoantibodies in MRL mice: in vitro detection and generation of antibody-forming cells. (1982) (36)
Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. (1996) (35)
Immunological and pathological consequences of mutations in both Fas and Fas ligand. (1998) (35)
T cells, murine chronic graft-versus-host disease and autoimmunity. (2012) (35)
Sm and DNA binding by dual reactive B cells requires distinct VH, V kappa, and VH CDR3 structures. (1995) (32)
Class II major histocompatibility antigens and the etiology of systemic lupus erythematosus. (1983) (32)
Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. (2007) (31)
The genetics of autoantibody production in MRL/lpr lupus mice. (1989) (31)
Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. (2010) (30)
Bifid origin of the left vertebral artery. (1986) (30)
The chronic graft-versus-host model of systemic autoimmunity. (2002) (29)
A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis. (2010) (29)
Regulation of the anti-Sm autoantibody response in systemic lupus erythematosus mice by monoclonal anti-Sm antibodies. (1990) (29)
Chronic graft versus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci. (1994) (29)
T Cell-Independent Spontaneous Loss of Tolerance by Anti-Double-Stranded DNA B Cells in C57BL/6 Mice1 (2008) (28)
The Role of Host CD4 T Cells in the Pathogenesis of the Chronic Graft-versus-Host Model of Systemic Lupus Erythematosus1 (2005) (28)
Secondary Heavy Chain Rearrangement (2003) (28)
Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor. (1988) (28)
Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. (1996) (28)
Subclass restriction of anti-SS-B (La) autoantibodies. (1986) (28)
The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice. (1994) (26)
B Cell Depletion with Anti-CD79 mAbs Ameliorates Autoimmune Disease in MRL/lpr Mice (2008) (26)
Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis (1985) (26)
Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. (1993) (26)
Chronic Graft-Versus-Host in Ig Knockin Transgenic Mice Abrogates B Cell Tolerance in Anti-Double-Stranded DNA B Cells (2002) (24)
Modulation of Autoimmunity by TLR9 in the Chronic Graft-vs-Host Model of Systemic Lupus Erythematosus1 (2006) (23)
Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras. (1998) (23)
Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20). (2006) (23)
MHC Class II-Bound Self Peptides from Autoimmune MRL/lpr Mice Reveal Potential T Cell Epitopes for Autoantibody Production in Murine Systemic Lupus Erythematosus1 (2000) (22)
B cell genotype determines the fine specificity of autoantibody in lpr mice. (1997) (22)
Absence of CD59 Exacerbates Systemic Autoimmunity in MRL/lpr Mice (2012) (22)
Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. (1997) (22)
T-B collaboration in the in vitro anti-Sm autoantibody response of MRL/Mp-lpr/lpr mice. (1988) (21)
MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. (1993) (21)
MHC genes modify systemic autoimmune disease. The role of the I-E locus. (1996) (20)
In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras. (1995) (20)
Characterization of functional T-cell lines derived from MRL mice. (1986) (20)
Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract. (1985) (20)
In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice (2010) (20)
Alu RNA-protein complexes formed in vitro react with a novel lupus autoantibody. (1985) (19)
Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene. (1992) (19)
The polypeptide structure of the Sm and RNP nuclear antigens. (1983) (19)
Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways (1986) (19)
The abnormal lpr double-negative T cell fails to proliferate in vivo. (1995) (18)
Idiotypic analysis of a monoclonal anti-Sm antibody. II. Strain distribution of a common idiotypic determinant and its relationship to anti-Sm expression. (1984) (18)
The role of antibodies in inflammatory arthritis (2010) (18)
Development of the T cell receptor repertoire in lpr mice. (1994) (17)
Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand. (1995) (16)
Regulation of anti-Sm autoantibodies by the immunoglobulin heavy chain locus. (1993) (16)
Aberrant expression of the very early activation antigen on MRL/Mp-lpr/lpr lymphocytes. (1993) (15)
Quantitation of the Sm nuclear antigen in tissues and activated lymphocytes. (1985) (15)
Antibodies in a Heavy Chain Knock-In Mouse Exhibit Characteristics of Early Heavy Chain Rearrangement1 (2009) (15)
Selection of Individual VH Genes Occurs at the Pro-B to Pre-B Cell Transition (2011) (15)
B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. (2010) (14)
Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes. (1981) (14)
Immunization with the Sm nuclear antigen induces anti-Sm antibodies in normal and MRL mice. (1988) (14)
Influence of the Ig H chain locus on autoantibody production in autoimmune mice. (1992) (14)
H-2-linked Ir gene control of T cell recognition of the Sm nuclear autoantigen and the aberrant response of autoimmune MRL/Mp-+/+ mice. (1985) (13)
Differential control of autoantibodies and lymphoproliferation by Fas ligand expression on CD4+ and CD8+ T cells in vivo. (1999) (13)
Distribution of lymphocytes identified by surface markers in murine strains with sle-like syndromes. Abstr. (1979) (13)
Mechanisms of systemic autoimmunity in murine models of SLE (1998) (13)
B-Cell Tolerance Defects in the B6.Aec1/2 Mouse Model of Sjögren’s Syndrome (2012) (12)
Murine monoclonal antibodies specific for conserved and non-conserved antigenic determinants of the human and murine Ku autoantigens (1993) (12)
Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency. (1985) (12)
Isotype analysis of the anti-CENP-B anticentromere autoantibody: evidence for restricted clonality. (1989) (12)
Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again (2006) (11)
The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes. (1987) (11)
Do autoantigens define autoimmunity or vice versa? (2005) (10)
The murine Sm-D autoantigen: multiple genes, genetic polymorphism, evolutionary conservation and lack of intervening sequences in the coding region. (1992) (10)
Tartrate‐resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese (2014) (10)
Mechanisms of autoimmunity (2003) (10)
Increased serum levels of tumor necrosis factor receptor-associated factor 1 (TRAF1) correlate with disease activity and autoantibodies in rheumatoid arthritis. (2016) (9)
Diminished expression of the T cell receptor on the expanded lymphocyte population in MRL/Mp-lpr/lpr mice. (1989) (9)
Cellular interactions for the in vitro production of anti-chromatin autoantibodies in MRL/Mp-lpr/lpr mice. (1989) (9)
The Role of CD5+ B Cells in the Production of Autoantibodies in Murine Systemic Lupus Erythematosus (1992) (9)
T cell recognition of the Sm nuclear antigen: induction of T cell proliferative responses in MRL/Mp- +/+ mice. (1982) (9)
Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors. (2003) (8)
Frequency and route of administration in the treatment of experimental arthritis by phosphorus-based dendrimer (2012) (8)
Mature B Cells Preferentially Lose Tolerance in the Chronic Graft-versus-Host Disease Model of Systemic Lupus Erythematosus1 (2007) (8)
Hidden autoantibodies against common serum proteins in murine systemic lupus erythematosus. Detection by in vitro plaque-forming cell assay (1985) (8)
CD3 expression, modulation and signalling in T-cell subpopulations from MRL/Mp-lpr/lpr mice. (1991) (7)
Antibody inhibition of the immune response: experimental analysis of the site of action in vivo. (1971) (7)
The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction. (2004) (6)
Chronic graft‐versus‐host reaction is associated with a decrease in Ig light chain receptor editing in bone marrow self‐reactive B cells (2004) (6)
IgM cryoprecipitation and anti-immunoglobulin activity in dysgammaglobulinemia type I. (1982) (6)
Tumor Necrosis Factor Receptor-associated Factor 1 influences KRN/I-Ag7 Mouse Arthritis Autoantibody Production (2013) (6)
Secondary receptor editing in the generation of autoimmunity. (2012) (6)
Immunological effects of recombinant interferon gamma in vivo in normal mice: failure to induce autoantibodies. (1990) (5)
Response of MRL/Mp-+/+ mice to mouse Sm: non-H-2-linked genes determine T cell recognition. (1985) (5)
Intrinsic unresponsiveness of Mertk-/- B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression. (2012) (5)
Disrupting Mer receptor tyrosine kinase expression prevents autoimmune chronic graft-versus-host disease (2007) (4)
Antinuclear antibodies and nuclear antigens in NZB myeloma ascitic fluids. (1985) (4)
KRN/I-Ag7 Mouse Arthritis Is Independent of Complement C3 (2011) (4)
Suppression and reversal of gld disease by parabiosis with normal mice. (1996) (4)
The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes. (1979) (4)
Immune Compromise Associated with Biologics (2014) (3)
Unusual acidic light chains in murine SLE serum. (1984) (3)
Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro (1987) (3)
Lupus erythematosus Chronic Graft-versus-Host Model of Systemic in the Pathogenesis of Nephritis in the TWEAK/Fn14 Interactions Are Instrumental (2007) (2)
Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity (2004) (2)
Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells. (1988) (2)
Combination biologics: 1 stone, 2 birds (2007) (1)
Southern blot analysis of major histocompatibility genes of lpr mice. (1988) (1)
Sm and DNA Binding by dual reactive B cells requires distinct V{sub H}, V{sub Îº}, and V{sub H} CDR3 structures (1995) (1)
Tissue expression pattern of the mouse GPI-DAF and its potential role in a murine model of autoimmune disease (2000) (1)
Subclass restriction of anti-sm antibody in mrl mice. Abstr. (1982) (1)
Targeting of T-B interaction using heteroconjugate antibody. (1991) (1)
Autoimmune The Role of Host (Endogenous) T Cells in (1998) (0)
the Pro-B to Pre-B Cell Transition Genes Occurs at H Selection of Individual V (0)
Cellular aspects of anti-sm production in mrl mice. Abstr. (1981) (0)
Lupus Erythematosus Marker Antibody Anti-Sm (2017) (0)
Introducing the Revised WEBbook of Biologics (2012) (0)
Isolation of Circulating Immune Complexes (1978) (0)
Secondary light chain gene rearrangements in the generation of anti-DNA autoantibodies in the chronic graft-versus-host model of SLE (44.15) (2011) (0)
Brief Definitive Report PRESENCE OF ANTI-Sm REACTIVITY IN AUTOIMMUNE MOUSE STRAINS * BY (2003) (0)
Lupus Erythematosus Chronic Graft-vs-Host Model of Systemic Modulation of Autoimmunity by TLR 9 in the (2006) (0)
S.127. Loss of B Cell Tolerance to DNA in the Murine Autoimmune Chronic Graft-versus-Host Reaction is Accompanied by Changes in Light-Chain Allele Use (2009) (0)
Subclass restricted igg polyclonal autoantibody formation in mice injected with lipid a-rich lipopolysaccharides. Abstr. (1980) (0)
wall-induced chronic erosive arthritis. tissues of rats resistant or susceptible to cell Measurement of streptococcal cell wall in (2013) (0)
Autoimmunity in MRL/lpr Mice Absence of CD59 Exacerbates Systemic (2012) (0)
Animal Model Deletion of Decay-Accelerating Factor (CD55) Exacerbates Autoimmune Disease Development in MRL/lpr Mice (2002) (0)
CD4 T cells must be present during B cell development for B cells to respond to a T-dependent foreign antigen (45.19) (2011) (0)
The influence of the immunoglobulin heavy chain locus on autoantibody production in autoimmune mice (1993) (0)
Clonal analysis of peripheral T cell precursors in lpr mice. (1992) (0)
Anti-idiotypic Antibodies to the Coombs Antibody in Nzb Fx Mice* (2003) (0)
Systemic Lupus Erythematosus the Chronic Graft-versus-Host Disease Model Required for the Loss of B Cell Tolerance in The Mer Receptor Tyrosine Kinase Is (2008) (0)
Suppression of male bxsb sle by female bxsb spleen cells. Abstr. (1981) (0)
OR.58Disrupting Mer Receptor Tyrosine Kinase Expression Prevents Autoimmune Chronic Graft-versus-host Disease (2007) (0)
B-Cell Tolerance Defects in the B6.Aec1/2 Mouse Model of Sjögren’s Syndrome (2012) (0)
Faculty Opinions recommendation of A defect in central tolerance in NOD mice. (2002) (0)
This information is current as-+ Mixed Chimeras lpr Revealed by Novel Immunoregulatory B Cell Pathways (1998) (0)
Heavy Chain Rearrangement Mouse Exhibit Characteristics of Early Antibodies in a Heavy Chain KnockIn Eisenberg and (2009) (0)
Tumor Necrosis Factor Receptor-associated Factor 1 influences KRN/I-Ag7 Mouse Arthritis Autoantibody Production (2013) (0)
CD4 T cells must be present during B cell development for B cells to respond to a T-dependent foreign antigen (2011) (0)
Commentary SLE Rituximab in lupus (2003) (0)
Tolerance by Anti-Double-Stranded DNA B T Cell-Independent Spontaneous Loss of (2017) (0)
Breakdown of autoreactive tolerance in mice deficient in apoptotic clearance (143.24) (2010) (0)
Biologic Therapies In Systemic Lupus Erythematosus (2009) (0)
Impaired CD1d downregulation on B cells limits the cGVH response in Mertk-/- mice (44.28) (2011) (0)
T Cells In + and CD8 + Expression on CD4 Lymphoproliferation by Fas Ligand Differential Control of Autoantibodies and (1999) (0)
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination (2012) (0)
Faculty Opinions recommendation of c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. (2001) (0)
Model of Systemic Lupus Erythematosus in the Chronic Graft-versus-Host Disease Mature B Cells Preferentially Lose Tolerance (2007) (0)
Spontaneous antiidiotypic antibodies to the NZB Coombs autoantibody. (1985) (0)
Murine Systemic Lupus Erythematosus T Cell Epitopes for Autoantibody Production Mice Reveal Potential / lpr Autoimmune MRL MHC Class II-Bound Self Peptides from Cohen and (2000) (0)
Tyrosine-Phosphoproteins Cell Receptor-Induced Tolerance : Changes in Coreceptors and B Model of B Cell Receptor Peripheral Induction of Autoimmunity in a Transgenic (1999) (0)
Cell transfer studies in autoimmune bxsb mice. Abstr. (1979) (0)
Cellular requirements for in vitro anti-sm production in mrl/mp-1pr/1pr mice. Abstr. (1982) (0)
The Mer Receptor Tyrosine Kinase Influences Toll-like Receptor Stimulation of Dendritic Cells (2007) (0)
Erythematosus Graft-versus-Host Model of Systemic Lupus Pathogenesis of the Chronic The Role of Host CD 4 T Cells in the and (2005) (0)
Endogenous CD4 T Cells Program B Cells to Respond in the Chronic GVH Model of SLE (2007) (0)
S.136. B Cells Need to be “Nurtured” by Endogenous CD4 T Cells in Order to Respond in the Chronic Graft-versus-host Model of Systemic Lupus Erythematosus or to Exogenous T-dependent Antigen (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert a. Eisenberg?

Robert a. Eisenberg is affiliated with the following schools:

Robert a. Eisenberg's Academic­Influence.com Rankings

Robert a. Eisenberg's Degrees

Why Is Robert a. Eisenberg Influential?

Robert a. Eisenberg's Published Works

Published Works

What Schools Are Affiliated With Robert a. Eisenberg?

Robert a. Eisenberg's AcademicInfluence.com Rankings